Part Details | ADENOVIRUS TYPE 4 A
6505-01-642-0106
Alternate Parts: NDC51285013850, NDC51285-0138-50, 1281637, 6505NCM151649, NDC51285013850, NDC51285-0138-50, 6505-01-642-0106, 01-642-0106, 6505016420106, 016420106
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-642-0106
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC51285-0138-50 | 56490 | BARR LABORATORIES, INC. |
| 1281637 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| 6505NCM151649 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
| NDC51285-0138-50 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. |
Technical Data | NSN 6505-01-642-0106
| Characteristic | Specifications |
|---|---|
| SPECIAL FEATURES | CONTAINS VIABLE, SELECTED STRAINS OF HUMAN ADENOVIRUS TYPE 4 AND HUMAN ADENOVIRUS TYPE 7 PREPARED IN HUMAN-DIPLOID FIBROBLAST CELL CULTURES (STRAIN WI-38); VIRUS STRAINS HAVE NOT BEEN ATTENUATED; CELLS ARE GROWN AND THE VIRUS GROWTH MAINTAINED IN DULBECCO'S MODIFIED EAGLE'S MEDIUM, FETAL BOVINE SERUM, AND SODIUM BICARBONATE; APPROVED FOR USE IN MILITARY POPULATIONS 17-50 YEARS OF AGE; INDICATED FOR ACTIVE IMMUNIZATION FOR THE PREVENTION OF FEBRILE ACUTE RESPIRATORY DISEASE CAUSED BY ADENOVIRUS TYPE 4 AND TYPE 7; CARTON CONSISTS OF ONE BOTTLE OF 100 TABLETS ADENOVIRUS TYPE 4 (NDC 51285-174-02) AND ONE BOTTLE OF 100 TABLETS ADENOVIRUS TYPE 7 (NDC 51285-175-02); STORE REFRIGERATED BETWEEN 2-8 DEG C (35-46 DEG F); DO NOT FREEZE; KEEP BOTTLE TIGHTLY CLOSED AND PROTECT FROM MOISTURE; DO NOT REMOVE DESICCANT CANISTER FROM BOTTLE; PRESCRIPTION ONLY; FOR ORAL ADMINISTRATION; DOSAGE: ONE TABLET OF ADENOVIRUS TYPE 4 COMPONENT AND ONE TABLET OF ADENOVIRUS TYPE 7 COMPONENT |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ADENOVIRUS TYPE 4 AND TYPE 7 VACCINE LIVE ORAL ENTERIC COATED TABLETS 200S |